Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Oral contraceptive use and clinical outcomes in patients with multiple sclerosis.
Implication of perturbed axoglial apparatus in early pediatric multiple sclerosis.
Trial watch: Chemotherapy with immunogenic cell death inducers.
Very early MS -- insights from MRI.
A practical guide to the treatment of neuromyelitis optica.
Central and Peripheral Nervous System Demyelination Following Mycoplasma Pneumonia Infection With Review of Literature.
Acorda Announces Initiation of Phase 3 Clinical Trial for Dalfampridine in Post-Stroke Walking Deficits
Immunology: A tolerant approach.
Do neutralising antibodies against exogenous interferon-beta inhibit endogenous signalling pathways?
Optical coherence tomography in multiple sclerosis.
The Ambivalent Role of Apoptosis in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis.
Peroxisome proliferator-activated receptor (PPAR)alpha expression in T cells mediates gender differences in development of T cell-mediated autoimmunity.
Cognitive impairment in neuro-Behcet's disease and multiple sclerosis: a comparative study.
Targeting IRF4 in autoimmune diseases.
Tumefactive MS lesions under fingolimod: A case report and literature review.
Enrollment complete for cannabinoid MS study
Natalizumab to fingolimod washout in patients at risk of PML: When good intentions yield bad outcomes.
Pain Research Forum: application of scientific social media frameworks in neuroscience.
Biogen Idec to present new two-year data from the PLEGRIDY™ (peginterferon beta-1a) Phase III advance study at AAN annual meeting
B-Cell Depletion Abrogates T Cell-Mediated Demyelination in an Antibody-Nondependent Common Marmoset Experimental Autoimmune Encephalomyelitis Model.
High-dose cyclophosphamide in the treatment of multiple sclerosis.
Interferon Beta Use and Disability Prevention in Relapsing-Remitting Multiple Sclerosis.
Causes of diplopia in the emergency department: diagnostic accuracy of clinical assessment and of head computed tomography.
Laquinimod CHMP/EMA opinion
Quality of life in the care home: a qualitative study of the perspectives of residents with multiple sclerosis.
Pages
« first
‹ previous
…
186
187
188
189
190
191
192
193
194
…
next ›
last »